Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 84-67-3 | MDL No. : | MFCD02269175 |
Formula : | C14H16N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QYIMZXITLDTULQ-UHFFFAOYSA-N |
M.W : | 212.29 | Pubchem ID : | 66537 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 70.62 |
TPSA : | 52.04 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.52 cm/s |
Log Po/w (iLOGP) : | 2.02 |
Log Po/w (XLOGP3) : | 2.92 |
Log Po/w (WLOGP) : | 3.15 |
Log Po/w (MLOGP) : | 2.95 |
Log Po/w (SILICOS-IT) : | 3.03 |
Consensus Log Po/w : | 2.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.48 |
Solubility : | 0.0695 mg/ml ; 0.000327 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.67 |
Solubility : | 0.045 mg/ml ; 0.000212 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.98 |
Solubility : | 0.00223 mg/ml ; 0.0000105 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.52 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | at 20℃; for 24h; | 5.00 g (23.55 mmol) of <strong>[84-67-3]4,4'-diamino-2,2'-dimethylbiphenyl</strong> (1) was ground into a powder, and then vigorously stirred in 337 mL of acetic anhydride, and reacted at room temperature for 24 hours. . After the reaction, the mixture was directly filtered, and the precipitate was collected and washed with water to neutral. After drying, 6.79 g of white solid (yield: 97percent).That is, 4,4'-diethylamino-2,2'-dimethylbiphenyl (2). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
methylamine, ...3,3'-dimethoxybenzidine, 3,3'-dichlorobenzidine, 3,3'-dicarboxybenzidine, 3,3'-dicarboxymethoxybenzidine, 2,2'-dimethylbenzidine, 4,2'-diaminodiphenyl (diphenyline), 2,6-diaminonaphthalene-4,8-disulfonic acid, 1,4-diaminobenzene-2-sulfonic acid, ... |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | Bis(4-diphenylamino)-<strong>[84-67-3]2,2'-dimethyl-4,4'-diaminobiphenyl</strong> (hereinafter abbreviated as BDDMD) represented by the formula (34) was prepared from p-hydroxydiphenylamine and 4,4'-diaminodiphenyl ether according to the following procedure (white solid, yield of 88percent). [Show Image] In 1 liter of toluene, 10.6145 g (0.05 mols) of <strong>[84-67-3]2,2'-dimethylbenzidine</strong> was dissolved. To obtain a dehydrating condensation agent, 153.144 g (0.45 mols) of titanium tetra-n-butoxide and 67.5765 g (0.45 mols) of p-tolyl acetate were evaporated on a water bath of 60°C for 60 minutes to completely distill off the resulting butyl acetate. This agent was added to the solution. While keeping the reaction solution at 110°C, 22.2264 g (0.12 mols) of p-hydroxydiphenylamine was added to the solution under nitrogen atmosphere, followed by reaction at the temperature for 48 hours under nitrogen atmosphere. After completion of the reaction, the reaction solution, cooled down to room temperature, was filtered and the resulting filtrate was washed with toluene and then with diethyl ether and dried to obtain white powder. The thus obtained crude product of BDDMD was purified according to the treatment with active carbon and recrystallization treatment as in Comparative Example 1. The recovery rate was at 98percent |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | e) Synthesis E 3,3'-dimethylbiphenyl-4,4'-dicarboxylic acid The reaction scheme for this synthesis is represented below: The same procedure as that described for synthesis D was used, starting with 12.1 g of dimethylbenzidine. After the first step, 18.4 g of 3,3'-dimethyl-4,4'-diiodobiphenyl are obtained (yield: 74percent). Characterization of the diiodo compound obtained: 1H NMR (300 MHz, CDCl3): delta (ppm): 2.54 (s, 6H), 7.10 (dd, J=2.2 and 8.1 Hz, 2H), 7.46 (d, J=2.2 Hz, 2H), 7.90 (d, J=8.1 Hz, 2H). 13C NMR (75 MHz, CDCl3): delta (ppm): 28.3 (CH3), 100.3 (Cq), 126.0 (CH), 128.3 (CH), 139.4 (CH), 140.4 (Cq), 141.9 (Cq). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | The reaction scheme of this synthesis is shown in .The same procedure as that described for synthesis B was used, starting from 12.1 g of dimethylbenzidine.At the end of the 1st step, 18.4 g of 3,3'-dimethyl-4,4'-diiodo-biphenyl is obtained (yield: 74percent).Characterization of the diiodinated compound obtained:1H NMR (300 MHz, CDCl3): delta (ppm): 2.54 (s, 6H), 7.10 (dd, J=2.2 and 8.1 Hz, 2H), 7.46 (d, J=2.2 Hz, 2H), 7.90 (d, J=8.1 Hz, 2H).13C NMR (75 MHz, CDCl3): delta (ppm): 28.3 (CH3), 100.3 (Cq), 126.0 (CH), 128.3 (CH), 139.4 (CH), 140.4 (Cq), 141.9 (Cq). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; In dichloromethane; at 20℃; for 2h; | General procedure: 5.1.1.14. (2S,2'S)-Di-tert-butyl 2,2'-(((3,3'-dimethyl-[1,1'-biphenyl]-4,4'-diyl)bis(azanediyl))bis(carbonyl))bis(pyrrolidine-1-carboxylate) (17). A mixture of N-Boc-L-proline (9.47 g, 44.0 mmol), EDCI(9.97 g, 52.0 mmol), and ortho-tolidine (4.25 g, 20.0 mmol) inCH2Cl2 (30 mL) was stirred at ambient temperature for 2 h. Theresulting residue was partitioned between CH2Cl2 and H2O. Theorganic layer was washed with 1.0 N aq HCl solution and brine,dried over MgSO4, filtered, and concentrated in vacuo. Without anypurification, 3 was obtained as a solid (11.3 g, 93percent).; 5.1.1.16 (2S,2'S)-Di-tert-butyl 2,2'-(((2,2'-dimethyl-[1,1'-biphenyl]-4,4'-diyl)bis(azanediyl))bis(carbonyl))bis(pyrrolidine-1-carboxylate) (19) Yield 2.75 g (96percent). 1H NMR (DMSO-d6, delta = 2.5 ppm, 400 MHz): 9.97 (s, 2H), 7.57-7.41 (m, 4H), 6.97 (app br s, 2H), 4.26 (m, 2H), 3.42-3.35 (m, 4H), 2.21 (m, 2H), 1.97 (s, 6H), 1.89-1.78 (m, 6H), 1.40-1.31 (app br s, 18H). 13C NMR (DMSO-d6, delta = 39.52 ppm, 100 MHz): 171.4, 171.0, 153.6, 153.2, 138.0, 138.0, 135.69, 135.65, 129.52, 120.48, 120.47, 120.4, 120.3, 116.7, 116.5, 78.6, 78.4, 60.3, 60.0, 46.7, 46.5, 31.3, 31.1, 30.2, 28.1, 28.0, 23.9, 23.3, 19.7. HRMS: Anal. calcd. for [M+H]+ C34H46N4O6: 607.3490; found 607.3489. |
96% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 2h; | Example 3 Preparation of dimethyl((1R,1'R)-((2S,2'S)-2,2'-(((2,2'-dimethyl-[1,1'-biphenyl]-4,4'-diyl)bis(azandiyl))bis(carbonyl))bis(pyrrolidine-2,1-diyl))bis(2-oxo-1-phenylethane-2,1-diyl))dicarbamate N-Boc-L-proline (2.23 g, 10.4 mmol), EDC (2.35 g, 12.3 mmol), and <strong>[84-67-3]meta-tolidine</strong> (1.0 g, 4.7 mmol) were mixed in CH2Cl2 (10 mL), followed by stirring at room temperature for 2 hours. Then, the compound obtained above was fractionated with CH2Cl2 and H2O. The organic layer was washed with 1 N HCl aqueous solution and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. Without any additional purification process, (2S,2'S)-di-tert-butyl 2,2'-(((2,2'-dimethyl-[1,1'-biphenyl]-4,4'-diyl)bis(azandiyl))bis(carbonyl))bis(pyrrolidine-1-carboxylate), the target compound, was obtained as a solid (2.75 g, yield: 96percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | With toluene-4-sulfonic acid; at 135℃; for 22h;Autoclave; Inert atmosphere; | In a 300mL autoclave, 42.4 g (0.200 mol) of m-toludine as a starting compound, 220 g (1.00 mol) of hexafluoroacetone trihydrate, 1.9 g (10 mmol) of p-toluenesulfonic acid monohydrate as a catalyst were added , The atmosphere is replaced by nitrogen and then sealed. The autoclave was heated to 135 ° C with an oil bath and stirred. After stirring for 22 hours, the autoclave was cooled to room temperature (20 ° C),then open and filter. The powder obtained by separation by filtration with diisopropyl ether was washed and dried under reduced pressure, 3,3 '-bis (1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl) -5,5' -dimethylbenzidine as a white powder 75.0 g (0.138 mol),with a yield of 69percent. The NMR measurement data is shown below. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
11.6 g | In toluene; at 80℃; for 7h; | A 4-necked flask equipped with a dropping funnel, a thermometer, a stirrer, a heating device and a cooling reflux tube was charged with <strong>[84-67-3]2,2'-dimethyl-4,4'-diaminobiphenyl</strong> TB-HG, manufactured by Wakayama Seika Kogyo Co., Ltd.), 30.0 g of a monopropargyl ether-containing mixture (C-1) was dissolved in 90 g of toluene, and then 94percent paraformaldehyde 7.0 g (0.21 mol) was added, the temperature was raised to 80 ° C with stirring, and the reaction was carried out at 80 ° C for 7 hours. After the reaction, move to a separatory funnel and remove the aqueous layer. After that, the solvent was removed from the organic layer under heating and reduced pressure to obtain 11.6 g of a compound (A-6). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With acetic acid; In toluene; for 1h;Inert atmosphere; Reflux; | In caseIn a separable flask,50 g (0.234 mol) of <strong>[84-67-3]2,2'-dimethylbiphenyl-4,4'-diamine</strong> (m-TB, manufactured by Wakayama Seika Industry Co., Ltd.)71 g (1.18 mol) of acetic acid and 120 g of toluene were charged and dissolved while heating and stirring at 50 ° C. while introducing nitrogen. 52.8 g (0.472 mol) of citraconic anhydride was added dropwise, and gradually heated while removing generated water outside the system,The reaction was carried out under reflux for 1 hour.After purifying the reaction product by reprecipitation, 90 g of a white crystal bismaleimide compound (e-1) was obtained. Yield 96percent. It was confirmed that the amine equivalent was 100,000 or more and almost all of the amino groups were reacted. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78.11% | 1) Clean all the glass instruments to be used in the experiment, dry and reserve, and install a mechanical stirring rod.First added to the 250mL three-necked flask of the nitrogen protection device<strong>[84-67-3]4,4'-diamino-2,2'-dimethylbiphenyl</strong> (6.7933 g, 32.0 mmol),Catalyst (1.1437g sodium carbonate, 0.1270g sodium hydroxide)And 10 mL of a mixed organic solvent 1,4-dioxane and toluene (volume ratio of 3:1), and heated to reflux until the solid is dissolved to obtain a mixed solution;2) 2,4-Dichloro-6-phenyl-1,3,5-triazine (0.9000 g, 4.0 mmol)Dissolved in 20 mL of 1,4-dioxane, the solution was added to the reaction flask through a constant pressure dropping funnel, and then fully refluxed for 6 h to obtain a mixed reaction solution;3) The reaction solution was poured into 60 mL of ice water, and after standing for a while, the solution was layered, the upper layer was a clear solution, the lower layer was solid precipitated, and the solid was subjected to column chromatography purification to obtain a volume ratio of ethyl acetate. : V petroleum ether = 1:1 as eluent, 1.7953 g of the target product conjugated diamine monomer was obtained, and the yield was 78.11%. |
Tags: 84-67-3 synthesis path| 84-67-3 SDS| 84-67-3 COA| 84-67-3 purity| 84-67-3 application| 84-67-3 NMR| 84-67-3 COA| 84-67-3 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :